3.1. epidemiology, aetiology pathophysiology. 3.1.1. introduction neuro-urological symptoms may caused variety diseases events affecting nervous system controlling lut. resulting neuro-urological symptoms depend predominantly location extent neurological lesion. exact figures overall prevalence neuro-urological disorders general population, data available prevalence underlying conditions relative risk development neuro-urological symptoms. important note majority data shows wide range prevalence/incidence. reflects variability cohort (e.g., early late-stage disease) frequently small sample sizes, resulting low level evidence published data (summarised table 1). table 1: epidemiology neuro-urological disorders suprapontine pontine lesions diseasesneurological diseasefrequency general populationtype frequency neuro-urological symptomscerebrovascular accident(strokes)450 cases/100,000/yr (europe) , 10% cardiovascular mortality.nocturia - overactive bladder (oab) - urgency urinary incontinence (uui) – neurogenic detrusor overactivity (ndo), patterns less frequent . 57-83% neuro-urological symptoms one month post-stroke, 71-80% spontaneous recovery six months . persistence urinary incontinence (ui) correlates poor prognosis .dementias:alzheimer’s disease (80%),vascular (10%), (10%).6.4% adults > 65 yrs .oab - uui – ndo, 25% incontinence alzheimer’sdisease, > 25% dementias: lewy body, nph, binswanger, nasu-hakola, pick disease . incontinence three times frequent geriatric patients dementia without .parkinsonian syndrome (ps)idiopathic parkinson’s disease (ipd): 75-80% ps.non-ipd: parkinson’s-plus (18%):- multiple system atrophy (msa),- progressive supranuclear palsy,- corticobasal degeneration,- dementia lewy bodies.secondary parkinson’s (2%)second prevalent neurodegenerative disease alzheimer’s disease.rising prevalence ipd age .msa frequentnon-ipd ps.luts affect 50% onset, urgency nocturia common. patients luts presentation worse disease progression parkinson’s disease . luts prevalence data depend gender, age, hoehn yahr stage .infections account major cause mortality msa .impaired detrusor contractility post-void residual (pvr) > 150 ml seems urodynamic finding distinguishing msa ipd [20-22].brain tumours26.8/100,000/yr adults (> 19 yrs), (17.9 benign, 8.9 malignant) .incontinence occurs mainly frontal location (part frontal syndrome isolated frontal location) .cerebral palsycerebral palsy: 3.1-3.6/1,000 children aged 8 yrs .32-46% patients cerebral palsy suffer ui, 85% patients abnormal urodynamic studies (ndo common 59%). upper tract deterioration rare (2.5%) .traumatic brain injury235/100,000/yr .44% storage dysfunction,38% voiding dysfunction,60% urodynamic abnormalities .normal pressure hydrocephalus0.5% population > 60, 2.9% > 65 .classic triad gait cognitive disturbance along neurogenic lower urinary tract dysfunction (nlutd). latter mainly related ndo affects 76-83% patients .lesions diseases caudal brainstem sacral spinal cordspinal cord injury (sci)prevalence traumatic sci indeveloped countries ranges 280 906/million .ndo detrusor sphincter dyssynergia (dsd) (up 95%) detrusor underactivity (du) (up 83%) depending level lesion .spina bifida (sb)spina bifida 3-4/10,000lumbar lumbosacral form common (60%) .bladder function impaired 96% sb patients . 50% patients incontinent . patients open closed defects equally severe nlutd .hereditary spastic paraplegia (hsp)prevalence 1.3-9/100,000 .luts 75%, mainly urgency voiding dysfunctionndo 81% (of 76% dsd) lesions diseases peripheral nervous systemlumbar spinedegenerative diseasedisk prolapselumbar canal stenosismale (5%) female (3%) > 35 yr. lumbosciaticepisode related disc prolapse.incidence: approx. 5/100,000/yrmore common females > 45 yr.26% difficulty void acontractile detrusor .detrusor underactivity (up 83%) .tarlov cysts: early sensation filling (70%), ndo (33%), stress urinary incontinence (sui) (33%) .iatrogenic pelvic nerve lesionsrectal cancer.cervical cancer (multimodaltherapy, radiotherapy surgery).endometriosis surgery.after abdomino-perineal resection: 50% urinary retention.after total mesorectal excision: 10-30% voiding dysfunction .peripheral neuropathydiabetesother causes peripheralneuropathy causing neuro-urological symptoms:- alcohol abuse;- lumbosacral zone andgenital herpes;- guillain barre syndrome;- porphyria;- sarcoidosis.worldwide, prevalence ofpharmacologically treated diabetes 8.3% .oab +/- uui .hypersensitivity du later phase .myasthenia gravisprevalence 20/100,000 increased daytime frequency, nocturia, incontinence disseminated central diseasesmultiple sclerosis (ms)prevalence: 83/100,000 europe .10% ms patients present withvoiding dysfunction disease onset, 75% patients develop 10 yrs ms .ndo: 65% , 43% .dsd: 35% .du: 25% .